These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 25996974

  • 1. 18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma.
    Dong Y, Zhang X, Wang S, Chen S, Ma C.
    Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):438-446. PubMed ID: 25996974
    [Abstract] [Full Text] [Related]

  • 2. Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma.
    Ricard F, Cimarelli S, Deshayes E, Mognetti T, Thiesse P, Giammarile F.
    Clin Nucl Med; 2011 Aug; 36(8):672-7. PubMed ID: 21716019
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. ¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas.
    Eugene T, Corradini N, Carlier T, Dupas B, Leux C, Bodet-Milin C.
    Nucl Med Commun; 2012 Oct; 33(10):1089-95. PubMed ID: 22929116
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S.
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [Abstract] [Full Text] [Related]

  • 7. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
    Schaarschmidt BM, Grueneisen J, Stebner V, Klode J, Stoffels I, Umutlu L, Schadendorf D, Heusch P, Antoch G, Pöppel TD.
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
    [Abstract] [Full Text] [Related]

  • 8. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis.
    Kroese TE, Goense L, van Hillegersberg R, de Keizer B, Mook S, Ruurda JP, van Rossum PSN.
    Dis Esophagus; 2018 Dec 01; 31(12):. PubMed ID: 29917073
    [Abstract] [Full Text] [Related]

  • 9. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.
    Acta Gastroenterol Belg; 2007 Dec 01; 70(4):331-8. PubMed ID: 18330088
    [Abstract] [Full Text] [Related]

  • 10. Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma.
    Karunanithi S, Sharma P, Roy SG, Vettiyil B, Sharma A, Thulkar S, Bal C, Kumar R.
    Clin Nucl Med; 2014 Sep 01; 39(9):772-6. PubMed ID: 25036015
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic performance of 18F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRI.
    Hotta M, Minamimoto R, Yano H, Gohda Y, Shuno Y.
    Cancer Imaging; 2018 Jan 30; 18(1):4. PubMed ID: 29378659
    [Abstract] [Full Text] [Related]

  • 12. Role of 18F-FDG-PET/CT in the staging of metastatic rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.
    Mercolini F, Zucchetta P, Jehanno N, Corradini N, Van Rijn RR, Rogers T, Cameron A, Scarzello G, Coppadoro B, Minard-Colin V, Gallego S, Chisholm J, Merks JH, Bisogno G.
    Eur J Cancer; 2021 Sep 30; 155():155-162. PubMed ID: 34385068
    [Abstract] [Full Text] [Related]

  • 13. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Kim HJ, Cho A, Yun M, Kim YT, Kang WJ.
    Ann Nucl Med; 2016 Feb 30; 30(2):104-13. PubMed ID: 26546334
    [Abstract] [Full Text] [Related]

  • 14. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
    Zhang C, Liang Z, Liu W, Zeng X, Mo Y.
    BMC Cancer; 2023 Jan 10; 23(1):37. PubMed ID: 36624425
    [Abstract] [Full Text] [Related]

  • 15. Breast cancer staging in a single session: whole-body PET/CT mammography.
    Heusner TA, Kuemmel S, Umutlu L, Koeninger A, Freudenberg LS, Hauth EA, Kimmig KR, Forsting M, Bockisch A, Antoch G.
    J Nucl Med; 2008 Aug 10; 49(8):1215-22. PubMed ID: 18632831
    [Abstract] [Full Text] [Related]

  • 16. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
    Ruhlmann V, Ruhlmann M, Bellendorf A, Grueneisen J, Sawicki LM, Grafe H, Forsting M, Bockisch A, Umutlu L.
    Eur J Radiol; 2016 Nov 10; 85(11):1941-1947. PubMed ID: 27776644
    [Abstract] [Full Text] [Related]

  • 17. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.
    Isohashi K, Tatsumi M, Higuchi I, Inoue A, Nakajo K, Ishikawa J, Shimosegawa E, Kanakura Y, Nakamura H, Hatazawa J.
    Ann Nucl Med; 2008 Nov 10; 22(9):795-802. PubMed ID: 19039558
    [Abstract] [Full Text] [Related]

  • 18. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.
    Scand J Urol Nephrol; 2011 Mar 10; 45(2):122-8. PubMed ID: 21231796
    [Abstract] [Full Text] [Related]

  • 19. Whole-Body [18F]FDG-PET/MRI vs. [18F]FDG-PET/CT in Malignant Melanoma.
    Berzaczy D, Fueger B, Hoeller C, Haug AR, Staudenherz A, Berzaczy G, Weber M, Mayerhoefer ME.
    Mol Imaging Biol; 2020 Jun 10; 22(3):739-744. PubMed ID: 31363965
    [Abstract] [Full Text] [Related]

  • 20. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME.
    Invest Radiol; 2016 Mar 10; 51(3):163-9. PubMed ID: 26784400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.